Urothelial carcinomas (UC) are the sixth-most common type of malignancy in developed countries, composed of bladder cancers (90-95%) and upper tract urothelial carcinomas (UTUC)(5-10%). UTUC have a peak incidence in individuals aged 70-90 years old, and are twice as common among men. Although UC can metastasize to any organ, the most common metastatic sites include lymph nodes, liver, lung, bone, and peritoneum. There are 98,000-170,000 cases of brain metastases each year, but brain metastases with a urothelial origin are a particularly rare occurrence, especially in the absence of other metastatic sites. Single lesions are more common than multiple metastases in UC patients with brain involvement. The most common locations for brain metastases are the frontal lobe, followed by the temporal and parietal lobes. While cases of UC metastases to the brain are rare, the prognosis is poor.